CRISPR Therapeutics
CRSP
#3222
Rank
$4.56 B
Marketcap
$47.57
Share price
7.28%
Change (1 day)
39.79%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement